{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:31:23Z","timestamp":1791930683811,"version":"4.3.4"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2"],"award-info":[{"award-number":["3\/1\/2"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cyto.2023.156347","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T06:05:26Z","timestamp":1693029926000},"page":"156347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis"],"prefix":"10.1016","volume":"170","author":[{"given":"Partha","family":"Pratim Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.cyto.2023.156347_b0010","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/apt.15255","article-title":"Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients","volume":"49","author":"Nilsson","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"10308","key":"10.1016\/j.cyto.2023.156347_b0015","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.cyto.2023.156347_b0020","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.cyto.2023.156347_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","article-title":"siRNA-and miRNA-based therapeutics for liver fibrosis","volume":"214","author":"Zhao","year":"2019","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.cyto.2023.156347_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.27318","article-title":"Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles","volume":"61","author":"Lemoinne","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0045","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41598-020-60615-0","article-title":"Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis","volume":"10","author":"Hoffmann","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2023.156347_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0966-6","article-title":"Advances and challenges in cirrhosis and portal hypertension","volume":"15","author":"Berzigotti","year":"2017","journal-title":"BMC Med."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0055","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"issue":"16","key":"10.1016\/j.cyto.2023.156347_b0060","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","article-title":"Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis","volume":"7","author":"Dirchwolf","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cyto.2023.156347_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fimmu.2014.00221","article-title":"Role of toll-like receptors in immune activation and tolerance in the liver","volume":"5","author":"Nakamoto","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2023.156347_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/192543","article-title":"Toll-like receptor signaling and liver fibrosis","volume":"2010","author":"Aoyama","year":"2010","journal-title":"Gastroenterol. Res. Pract."},{"issue":"10","key":"10.1016\/j.cyto.2023.156347_b0075","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3748\/wjg.v20.i10.2564","article-title":"Immune dysfunction in cirrhosis","volume":"20","author":"Sipeki","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.cyto.2023.156347_b0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis","volume":"10","author":"Irvine","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.cyto.2023.156347_b0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/intimm\/dxac030","article-title":"Liver cirrhosis and immune dysfunction","volume":"34","author":"Hasa","year":"2022","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156347_b0095","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/ar.24829","article-title":"Alcohol-associated capillarization of sinusoids: A critique since the discovery by Schaffner and Popper in 1963","volume":"305","author":"Mak","year":"2022","journal-title":"Anat. Rec."},{"key":"10.1016\/j.cyto.2023.156347_b0100","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2147\/TCRM.S115902","article-title":"Intestinal permeability in a patient with liver cirrhosis","author":"Aguirre Valadez","year":"2016","journal-title":"Ther. Clin. Risk Manag."},{"issue":"20","key":"10.1016\/j.cyto.2023.156347_b0105","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.cyto.2023.156347_b0110","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2023.156347_b0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40139-015-0093-z","article-title":"TNF\u03b1 in liver fibrosis","volume":"3","author":"Yang","year":"2015","journal-title":"Curr. Pathobiol. Rep."},{"key":"10.1016\/j.cyto.2023.156347_b0120","first-page":"297","article-title":"Interleukins in chronic liver disease: lessons learned from experimental mouse models","author":"Hammerich","year":"2014","journal-title":"Clin. Exp. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","article-title":"Role of inflammatory response in liver diseases: Therapeutic strategies","volume":"10","author":"Del Campo","year":"2018","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cyto.2023.156347_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression","volume":"12","author":"Fontes-Cal","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.20517\/2394-5079.2015.58","article-title":"Physiological potential of cytokines and liver damages","volume":"2","author":"Mannaa","year":"2016","journal-title":"Hepatoma Res."},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156347_b0150","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1478-3231.2006.01327.x","article-title":"Role of neutrophils in acute inflammatory liver injury","volume":"26","author":"Jaeschke","year":"2006","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/17474124.2.2.233","article-title":"Chemokine-directed immune cell infiltration in acute and chronic liver disease","volume":"2","author":"Karlmark","year":"2008","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0160","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. I. TNF-\u03b1-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am. J. Physiol.-Gastrointestinal and Liver Physiol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156347_b0165","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0006-2952(03)00491-X","article-title":"Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease","volume":"66","author":"Heyninck","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0170","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1074\/jbc.M112.419788","article-title":"Interleukin-6\/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: a masterplayer in the cytokine network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0180","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer","volume":"44","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cyto.2023.156347_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cancers11010024","article-title":"Obesity-induced TNF\u03b1 and IL-6 signaling: the missing link between obesity and inflammation\u2014driven liver and colorectal cancers","volume":"11","author":"Kern","year":"2018","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.cyto.2023.156347_b0195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: Biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0200","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.cyto.2023.156347_b0205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1478-3231.2006.01339.x","article-title":"How to modulate inflammatory cytokines in liver diseases","volume":"26","author":"Tilg","year":"2006","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/wound.2019.1032","article-title":"The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis","volume":"9","author":"Steen","year":"2020","journal-title":"Adv. Wound Care"},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O'Garra","year":"2008","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0220","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/vim.2019.0170","article-title":"IL-10 polymorphisms and haplotypes predict susceptibility to hepatocellular carcinoma occurrence in patients with hepatitis C virus infection from Northeast India","volume":"33","author":"Barooah","year":"2020","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","article-title":"Commentary: IL-4 and IL-13 receptors and signaling","volume":"75","author":"McCormick","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0230","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156347_b0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156347_b0240","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cyto.2023.156347_b0245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2023.156347_b0250","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JIR.S277457","article-title":"Role of caspase-1 in the pathogenesis of inflammatory-associated chronic noncommunicable diseases","author":"Molla","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0255","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0260","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cyto.2023.156347_b0265","article-title":"Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis","author":"Knorr","year":"2022","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cyto.2023.156347_b0270","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0275","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.24599","article-title":"An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice","volume":"54","author":"Mandrekar","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0280","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2023.156347_b0290","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3390\/ijms23094986","article-title":"Regulatory roles of caspase-11 non-canonical inflammasome in inflammatory liver diseases","volume":"23","author":"Yi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0295","doi-asserted-by":"crossref","first-page":"e2119","DOI":"10.1371\/journal.pone.0002119","article-title":"The Nod-like receptor (NLR) family: a tale of similarities and differences","volume":"3","author":"Proell","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.3MR0617-250R","article-title":"Molecular mechanisms of inflammasome signaling","volume":"103","author":"Mathur","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"23","key":"10.1016\/j.cyto.2023.156347_b0305","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1242\/jcs.207365","article-title":"Inflammasome activation and assembly at a glance","volume":"130","author":"Malik","year":"2017","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0310","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am. J. Physiol.-Gastrointestinal and Liver Physiol."},{"key":"10.1016\/j.cyto.2023.156347_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-9255-9-49","article-title":"Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease","volume":"9","author":"Boaru","year":"2012","journal-title":"J. Inflamm."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0320","first-page":"1","article-title":"New insights into Nod-like receptors (NLRs) in liver diseases","volume":"10","author":"Xu","year":"2018","journal-title":"Int. J. Physiology, Pathophysiology and Pharmacology"},{"issue":"7","key":"10.1016\/j.cyto.2023.156347_b0325","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"Seki","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2023.156347_b0330","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3389\/fimmu.2018.02201","article-title":"Inflammasome: a double-edged sword in liver diseases","volume":"9","author":"Luan","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0340","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cells6040048","article-title":"Differential location and distribution of hepatic immune cells","volume":"6","author":"Freitas-Lopes","year":"2017","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.cyto.2023.156347_b0345","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.3390\/cells9122632","article-title":"Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure","volume":"9","author":"Casulleras","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2023.156347_b0350","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15644","article-title":"Mechanisms of immunity in acutely decompensated cirrhosis and acute-on-chronic liver failure","author":"Engelmann","year":"2023","journal-title":"Liver Int."},{"issue":"41","key":"10.1016\/j.cyto.2023.156347_b0355","doi-asserted-by":"crossref","first-page":"11522","DOI":"10.3748\/wjg.v21.i41.11522","article-title":"Inflammatory status in human hepatic cirrhosis","volume":"21","author":"Mart\u00ednez-Esparza","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0360","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0365","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0370","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.30252","article-title":"NLR family pyrin domain-containing 3 inflammasome activation in hepatic stellate cells induces liver fibrosis in mice","volume":"69","author":"Inzaugarat","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2023.156347_b0375","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3389\/fimmu.2017.01728","article-title":"Relevance of the NLRP3 inflammasome in the pathogenesis of chronic liver disease","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156347_b0380","doi-asserted-by":"crossref","first-page":"e0263931","DOI":"10.1371\/journal.pone.0263931","article-title":"Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"17","author":"Fern\u00e1ndez","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cyto.2023.156347_b0385","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/ijms20112712","article-title":"Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease","volume":"20","author":"Kong","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2023.156347_b0390","doi-asserted-by":"crossref","first-page":"208","DOI":"10.23736\/S1121-421X.18.02461-3","article-title":"Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease","volume":"64","author":"Ivashkin","year":"2018","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"10.1016\/j.cyto.2023.156347_b0395","doi-asserted-by":"crossref","unstructured":"Rivkin, A., Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B. Drugs of Today (Barcelona, Spain: 1998), 2007. 43(4): p. 201-220.","DOI":"10.1358\/dot.2007.43.4.1430649"},{"issue":"10","key":"10.1016\/j.cyto.2023.156347_b0400","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/cid\/ciz022","article-title":"Safety and pharmacokinetics of glecaprevir\/pibrentasvir in adults with chronic genotype 1\u20136 hepatitis C virus infections and compensated liver disease","volume":"69","author":"Gane","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.cyto.2023.156347_b0405","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hup.1244","article-title":"Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver disease","volume":"26","author":"Leggio","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0410","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/MEG.0000000000001786","article-title":"Efficacy of sofosbuvir\/velpatasvir\/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus","volume":"33","author":"Da","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156347_b0415","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/ph11040104","article-title":"Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease","volume":"11","author":"Abenavoli","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cyto.2023.156347_b0420","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00005344-199322003-00007","article-title":"Loop diuretic therapy in liver cirrhosis with ascites","volume":"22","author":"Laffi","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.dld.2016.09.013","article-title":"Beta blockers and cirrhosis, 2016","volume":"49","author":"Mandorfer","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.cyto.2023.156347_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DDDT.S172324","article-title":"Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy","author":"Wang","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.cyto.2023.156347_b0435","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0440","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-3476(00)05040-X","article-title":"Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study","volume":"136","author":"Lavine","year":"2000","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.cyto.2023.156347_b0445","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156347_b0450","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181304","article-title":"Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","volume":"38","author":"Tian","year":"2018","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2023.156347_b0455","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.20012","article-title":"A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis","volume":"39","author":"Promrat","year":"2004","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.cyto.2023.156347_b0460","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2169\/internalmedicine.4398-19","article-title":"SGLT2 inhibitor treatment outcome in nonalcoholic fatty liver disease complicated with diabetes mellitus: the long-term effects on clinical features and liver histopathology","volume":"59","author":"Akuta","year":"2020","journal-title":"Intern. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:07:07Z","timestamp":1736399227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":92,"alternative-id":["S1043466623002259"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156347","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156347"}}